Erik Pong

Potent <i>In vitro</i> and <i>In vivo</i> Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia

Holly M. Horton, Matthew J. Bernett, Erik Pong et al. · Cancer Research · 2008 · 271 citations · Full text

Pharmacy, Immunology, Oncology +17

Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies

Seung Y. Chu, Igor Voštiar, Sher Karki et al. · Molecular Immunology · 2008 · 155 citations

Life Sciences, Cell Biology, Immunology +11

Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus

Holly M. Horton, Seung Y. Chu, Elizabeth Ortiz et al. · The Journal of Immunology · 2011 · 144 citations

Life Sciences, Immunology, Pathobiology +17

A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens

Gregory L. Moore, Cristina Bautista, Erik Pong et al. · mAbs · 2011 · 103 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody

Seung Y. Chu, Holly M. Horton, Erik Pong et al. · Journal of Allergy and Clinical Immunology · 2012 · 93 citations

Life Sciences, Biotechnology, Immunology +17